Clinical Trials Browser

niraparib × Gastrointestinal × 30 days × Clear all

NCT03601923 2026-03-25

Niraparib in Patients With Pancreatic Cancer

Phase 2 Completed

Gastrointestinal

Pancreatic Neoplasms